Huntsman Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Huntsman Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| operating activities: | |||||||||
| net income | -145,000,000 | 11,000,000 | -125,000,000 | -70,900,000 | 46,600,000 | -18,800,000 | -83,300,000 | 262,900,000 | 69,000,000 |
| less: income from discontinued operations, net of tax | 1,000,000 | ||||||||
| income from continuing operations | -146,000,000 | 12,000,000 | -110,000,000 | ||||||
| adjustments to reconcile income from continuing operations to net cash from operating activities from continuing operations: | |||||||||
| equity in loss (income) of investment in unconsolidated affiliates | |||||||||
| cash received from return on investment in unconsolidated affiliates | |||||||||
| depreciation and amortization | 72,000,000 | 69,000,000 | 75,000,000 | 107,800,000 | 109,200,000 | 112,500,000 | 118,700,000 | 117,500,000 | 117,000,000 |
| noncash lease expense | 17,000,000 | 19,000,000 | 19,000,000 | ||||||
| gain on acquisition of assets | 0 | -5,000,000 | 0 | ||||||
| noncash prepaid asset write-off | 0 | ||||||||
| noncash restructuring and impairment charges | |||||||||
| deferred income taxes | -1,000,000 | -1,000,000 | -11,000,000 | 69,900,000 | 4,200,000 | -16,400,000 | 11,100,000 | 7,300,000 | |
| noncash stock-based compensation | 7,000,000 | 9,000,000 | |||||||
| other | 1,000,000 | 3,000,000 | -10,000,000 | 6,600,000 | 3,200,000 | 2,000,000 | |||
| changes in operating assets and liabilities: | |||||||||
| accounts and notes receivable | 2,000,000 | -65,000,000 | 79,000,000 | ||||||
| inventories | 160,000,000 | -101,000,000 | 60,000,000 | 1,399,100,000 | -1,287,900,000 | 1,311,000,000 | |||
| prepaid expenses | 24,000,000 | 26,000,000 | 15,900,000 | 10,300,000 | 70,800,000 | -5,300,000 | 6,600,000 | ||
| other current assets | 4,000,000 | -1,000,000 | 24,000,000 | 37,000,000 | 5,000,000 | 81,400,000 | -8,300,000 | 46,900,000 | |
| other noncurrent assets | -23,000,000 | -3,000,000 | -138,000,000 | -398,200,000 | -74,800,000 | 625,300,000 | 10,500,000 | ||
| accounts payable | -62,000,000 | -32,000,000 | 48,000,000 | -33,200,000 | 46,100,000 | -47,000,000 | -1,065,500,000 | 140,000,000 | 994,000,000 |
| accrued liabilities | -53,000,000 | 33,000,000 | 2,000,000 | -563,600,000 | -58,300,000 | 69,600,000 | 574,300,000 | ||
| other noncurrent liabilities | -11,000,000 | -33,000,000 | 90,000,000 | -42,300,000 | 159,700,000 | 775,100,000 | |||
| net cash from operating activities from continuing operations | 92,000,000 | -71,000,000 | 159,000,000 | ||||||
| net cash from operating activities from discontinued operations | -1,000,000 | -3,000,000 | -6,000,000 | ||||||
| net cash from operating activities | 91,000,000 | -74,000,000 | 153,000,000 | 282,200,000 | 287,400,000 | 243,200,000 | 80,300,000 | ||
| investing activities: | |||||||||
| capital expenditures | -37,000,000 | -36,000,000 | -51,000,000 | ||||||
| free cash flows | 54,000,000 | -110,000,000 | 102,000,000 | ||||||
| cash received from return of investment in unconsolidated subsidiary | 0 | 41,000,000 | 0 | ||||||
| cash received from sale of businesses | 0 | ||||||||
| net cash from investing activities | -38,000,000 | 6,000,000 | -39,000,000 | ||||||
| financing activities: | |||||||||
| net borrowings on revolving loan facilities | 54,000,000 | 427,000,000 | |||||||
| repayments of long-term debt | -3,000,000 | -319,000,000 | -5,000,000 | ||||||
| principal payments on note payable | 0 | ||||||||
| dividends paid to common stockholders | -43,000,000 | -44,000,000 | -44,000,000 | ||||||
| distributions paid to noncontrolling interests | -42,000,000 | ||||||||
| repurchase and cancellation of awards | 0 | -3,000,000 | |||||||
| repurchase of common stock | -3,000,000 | ||||||||
| net cash from financing activities | 9,000,000 | 60,000,000 | -95,000,000 | 57,200,000 | 6,700,000 | 37,000,000 | |||
| effect of exchange rate changes on cash | 3,000,000 | 2,000,000 | -9,000,000 | 1,600,000 | 3,600,000 | 12,700,000 | |||
| increase in cash and cash equivalents | 65,000,000 | -6,000,000 | 17,400,000 | 45,700,000 | 49,800,000 | 7,500,000 | |||
| cash and cash equivalents at beginning of period | 0 | 340,000,000 | 0 | 0 | 263,200,000 | 0 | 0 | 0 | 142,800,000 |
| cash and cash equivalents at end of period | 65,000,000 | 334,000,000 | 10,000,000 | 24,000,000 | 143,500,000 | 17,400,000 | 45,700,000 | 49,800,000 | 150,300,000 |
| supplemental cash flow information: | |||||||||
| cash paid for interest | 36,000,000 | 8,000,000 | 22,000,000 | 81,400,000 | 69,800,000 | 81,900,000 | 131,700,000 | 59,700,000 | 123,200,000 |
| cash paid for income taxes | 49,000,000 | 12,000,000 | 30,000,000 | 22,000,000 | 11,800,000 | 12,500,000 | 15,400,000 | 7,400,000 | 5,000,000 |
| assets | |||||||||
| current assets: | |||||||||
| cash and cash equivalents | 65,000,000 | 334,000,000 | 43,300,000 | 49,600,000 | 136,600,000 | ||||
| accounts receivable from affiliates | 0 | 8,000,000 | 2,700,000 | 8,100,000 | 12,100,000 | ||||
| total current assets | -78,000,000 | 2,286,000,000 | 114,700,000 | 616,400,000 | 2,992,300,000 | ||||
| property, plant and equipment | -3,000,000 | 2,494,000,000 | -646,000,000 | 67,800,000 | 4,286,000,000 | ||||
| investment in unconsolidated affiliates | -18,000,000 | 317,000,000 | 1,200,000 | 1,200,000 | 197,300,000 | ||||
| intangible assets | -6,000,000 | 334,000,000 | -8,700,000 | -5,800,000 | 214,500,000 | ||||
| goodwill | -6,000,000 | 637,000,000 | 0 | 100,000 | 91,200,000 | ||||
| operating lease right-of-use assets | -9,000,000 | 381,000,000 | |||||||
| total assets | -85,000,000 | 7,232,000,000 | -14,200,000 | 621,300,000 | 8,595,800,000 | ||||
| liabilities and equity | |||||||||
| current liabilities: | |||||||||
| accounts payable to affiliates | 6,000,000 | 15,000,000 | -1,900,000 | 200,000 | 6,300,000 | ||||
| current portion of debt | 88,000,000 | 284,000,000 | |||||||
| current operating lease liabilities | -1,000,000 | 58,000,000 | |||||||
| total current liabilities | 6,000,000 | 1,535,000,000 | 216,100,000 | 336,700,000 | 1,658,300,000 | ||||
| long-term debt | -7,000,000 | 1,670,000,000 | -159,600,000 | -207,200,000 | 4,465,900,000 | ||||
| noncurrent operating lease liabilities | 1,000,000 | 343,000,000 | |||||||
| total liabilities | 20,000,000 | 4,059,000,000 | -21,700,000 | 338,800,000 | 7,131,700,000 | ||||
| commitments and contingencies | |||||||||
| equity | |||||||||
| huntsman international llc members’ equity: | |||||||||
| members’ equity, 2,728 units issued and outstanding | 8,000,000 | 3,821,000,000 | 4,700,000 | ||||||
| retained earnings | -199,000,000 | 284,000,000 | |||||||
| accumulated other comprehensive loss | 73,000,000 | -1,152,000,000 | |||||||
| total huntsman international llc members’ equity | -118,000,000 | 2,953,000,000 | |||||||
| noncontrolling interests in subsidiaries | 13,000,000 | 220,000,000 | |||||||
| total equity | -105,000,000 | 3,173,000,000 | |||||||
| total liabilities and equity | -85,000,000 | 7,232,000,000 | |||||||
| equity in income of investment in unconsolidated affiliates | -1,000,000 | -2,000,000 | |||||||
| less: loss (income) from discontinued operations, net of tax | 15,000,000 | ||||||||
| cash received from return on investment in unconsolidated subsidiary | 11,000,000 | ||||||||
| loss on dissolution of subsidiaries | |||||||||
| stock-based compensation | 6,600,000 | 5,300,000 | 5,400,000 | 4,800,000 | 4,700,000 | 3,500,000 | |||
| receivable associated with the albemarle settlement | |||||||||
| cash received from sale of assets | |||||||||
| insurance proceeds for recovery of property damage | |||||||||
| net cash from investing activities from continuing operations | -39,000,000 | ||||||||
| net cash from investing activities from discontinued operations | |||||||||
| net (repayments) borrowings on revolving loan facilities | |||||||||
| proceeds from long-term debt | 0 | 97,100,000 | 169,000,000 | 735,200,000 | 114,300,000 | 20,400,000 | 2,500,000 | ||
| repurchase and cancellation of stock awards | |||||||||
| proceeds from issuance of common stock | |||||||||
| decrease in cash and cash equivalents | 10,000,000 | ||||||||
| • | |||||||||
| net repayments on revolving loan facilities | |||||||||
| net borrowings (repayments) on revolving loan facilities | |||||||||
| unrealized losses on fair value adjustments to venator investment | |||||||||
| gain on disposal of businesses/assets | |||||||||
| loss on early extinguishment of debt | 400,000 | 1,400,000 | 12,600,000 | ||||||
| acquisition of businesses, net of cash acquired | |||||||||
| proceeds from issuance of long-term debt | |||||||||
| costs of early extinguishment of debt | |||||||||
| current assets held for sale | 79,900,000 | ||||||||
| current liabilities held for sale | 39,200,000 | ||||||||
| unrealized net incomees on fair value adjustments to venator investment | |||||||||
| unrealized losses on fair value adjustments to venator investment, net and related loss on disposal | |||||||||
| taxes paid on chemical intermediates businesses | |||||||||
| cash received from the sale of venator shares | |||||||||
| proceeds from sale of assets | 0 | 15,800,000 | 7,900,000 | 192,600,000 | 8,500,000 | ||||
| repayments of short-term debt | |||||||||
| repayments of notes payable | |||||||||
| cash and cash equivalents from continuing operations at beginning of period | |||||||||
| cash received from sale of business | |||||||||
| acquisition of business, net of cash acquired | |||||||||
| debt issuance costs paid | |||||||||
| dividends paid to noncontrolling interests | |||||||||
| noncurrent assets held for sale | 86,400,000 | ||||||||
| noncurrent liabilities held for sale | 1,300,000 | ||||||||
| unrealized losses on fair value adjustments to venator investment and related loss on disposal | |||||||||
| cash received from forward swap contract related to the sale of investment in venator | |||||||||
| borrowings on short-term debt | |||||||||
| borrowings on note payable | |||||||||
| cash paid for noncontrolling interest | |||||||||
| taxes paid on sale of chemical intermediates businesses | |||||||||
| increase in cash, cash equivalents and restricted cash | |||||||||
| cash, cash equivalents and restricted cash at beginning of period | |||||||||
| cash, cash equivalents and restricted cash at end of period | |||||||||
| less: (income) income from discontinued operations, net of tax | |||||||||
| (gain) loss on disposal of businesses/assets | |||||||||
| proceeds from the secondary offering of venator | |||||||||
| cash, cash equivalents and restricted cash from continuing operations at beginning of period | |||||||||
| cash, cash equivalents and restricted cash from discontinued operations at beginning of period | |||||||||
| deconsolidation of cash, cash equivalents and restricted cash from venator | |||||||||
| | |||||||||
| acquisition of a businesses, net of cash acquired | |||||||||
| borrowings on notes payable | |||||||||
| cash paid for noncontrolling interests | |||||||||
| unrealized losses (gains) on fair value adjustments to venator investment | |||||||||
| taxes paid on sale of business | |||||||||
| acquisition of a business, net of cash acquired | |||||||||
| reimbursements of capital expenditures | |||||||||
| noncash interest expense | 1,000,000 | 1,000,000 | |||||||
| noncash gain on foreign currency transactions | |||||||||
| cash received from termination of cross-country interest rate contacts | |||||||||
| net (repayments) borrowings on overdraft facilities | |||||||||
| proceeds from long-term debt of venator | |||||||||
| contribution from noncontrolling interests | |||||||||
| proceeds from the ipo of venator | |||||||||
| cash paid for expenses for the ipo of venator | |||||||||
| cash paid for expenses of the secondary offering of venator | |||||||||
| noncash loss on foreign currency transactions | |||||||||
| unrealized gains on fair value adjustments to venator investment | |||||||||
| loss on disposal of businesses/assets | |||||||||
| noncash restructuring and impairment (credits) charges | |||||||||
| changes in operating assets and liabilities, net of effects of acquisitions: | |||||||||
| proceeds from sale of businesses/assets | |||||||||
| cash received from termination of cross-currency interest rate contracts | |||||||||
| net borrowings (repayments) under revolving loan facilities | 34,000,000 | ||||||||
| call premiums related to early extinguishment of debt | |||||||||
| adjustments to reconcile net income to net cash from operating activities: | |||||||||
| extraordinary gain on the acquisiton of business, net of tax | |||||||||
| benefit from losses on accounts receivable | 1,700,000 | 2,700,000 | 2,900,000 | ||||||
| gain on disposal of assets | |||||||||
| noncash restructuring, impairment and plant closing costs | 5,900,000 | 5,800,000 | 1,300,000 | 4,500,000 | 10,300,000 | 2,000,000 | |||
| impairment loss on pending disposal of discontinued operations | |||||||||
| net unrealized (gain) loss on foreign currency transactions | |||||||||
| minority interest in subsidiaries’ income | 400,000 | 1,800,000 | 400,000 | 300,000 | 400,000 | ||||
| acquisition of business, net of cash acquired and post-closing adjustments | |||||||||
| proceeds from government securities, restricted as to use | 3,600,000 | 3,600,000 | |||||||
| change in restricted cash | |||||||||
| net repayments from overdraft facilities and other short-term debt | |||||||||
| repayments on notes payable | |||||||||
| proceeds from notes payable | 2,500,000 | 4,700,000 | |||||||
| dividends paid to preferred stockholders | |||||||||
| contribution from minority shareholder | 0 | 0 | 0 | 6,200,000 | |||||
| change in capital expenditures included in accounts payable | |||||||||
| accounts and notes receivables | |||||||||
| liabilities and members’ equity | |||||||||
| current portion of long-term debt | 54,300,000 | 130,300,000 | 42,000,000 | ||||||
| minority interests in common stock of consolidated subsidiaries | 1,800,000 | ||||||||
| members’ equity: | |||||||||
| accumulated deficit | |||||||||
| total members’ equity | 5,700,000 | 282,200,000 | 1,436,700,000 | ||||||
| total liabilities and members’ equity | -14,200,000 | 621,300,000 | 8,595,800,000 | ||||||
| equity in income of unconsolidated affiliates | |||||||||
| net borrowings under revolving loan facilities | 93,700,000 | ||||||||
| net borrowings from overdraft facilities and other short-term debt | 12,300,000 | ||||||||
| dividends paid to common shareholders | |||||||||
| extraordinary gain on the acquistion of a business, net of tax | |||||||||
| cumulative effect of changes in accounting principle, net of tax | |||||||||
| acquisition of minority interest | |||||||||
| net investment in government securities, restricted as to use | |||||||||
| net (repayments) borrowings under revolving loan facilities | |||||||||
| net repayments of overdraft and other short-term debt | |||||||||
| net borrowings (repayments) on notes payable | |||||||||
| dividend paid to preferred stockholders | |||||||||
| net proceeds from issuance of common and preferred stock | |||||||||
| /s/ deloitte & touche llp | |||||||||
| houston, texas | |||||||||
| february 28, 2007 | |||||||||
| extraordinary gain on the acquisition of a business, net of tax | |||||||||
| cumulative effect of change in accounting principle, net of tax | |||||||||
| (gain) loss on disposal of assets | |||||||||
| loss on pending disposal of discontinued operations | |||||||||
| noncash interest income | |||||||||
| accounts receivable | 118,900,000 | -51,500,000 | 114,800,000 | ||||||
| net proceeds from (investment in) government securities, restricted as to use | 3,600,000 | 3,600,000 | 3,600,000 | ||||||
| net (repayments) borrowings on overdraft | |||||||||
| repayment of long-term debt | |||||||||
| net borrowings on notes payable | |||||||||
| notes receivable from affiliates | 1,000,000 | ||||||||
| accumulated other comprehensive income | 59,800,000 | ||||||||
| benefit from (reversal of) losses on accounts receivable | 0 | 2,200,000 | |||||||
| net unrealized loss on foreign currency transactions | 20,200,000 | 6,700,000 | |||||||
| net repayments under revolving loan facilities | |||||||||
| net repayments on overdraft facility | |||||||||
| repayment of notes payable | |||||||||
| restricted cash | |||||||||
| change in receivables sold | |||||||||
| net borrowings on overdraft | 8,100,000 | ||||||||
| minority interests | 27,400,000 | ||||||||
| members’ equity, 2,113 units issued and outstanding | 2,797,500,000 | ||||||||
| loss on disposal of assets | |||||||||
| loss on disposal of discontinued operations | |||||||||
| net unrealized gain on foreign currency transactions | |||||||||
| acquisition of minority interests | |||||||||
| net cash received from unconsolidated affiliates | |||||||||
| net investment in government securities, resticted as to use | |||||||||
| advances to unconsolidated affiliates | |||||||||
| principal payments on notes payable | |||||||||
| net (repayment) borrowings under revolving loan facilities | |||||||||
| repayment of long-term debt and notes payable | |||||||||
| debt issuance costs | |||||||||
| cost of early extinguishment of debt | |||||||||
| raw materials and supplies | |||||||||
| work in progress | |||||||||
| finished goods | |||||||||
| total | |||||||||
| lifo reserves | |||||||||
| lower of cost or market reserves |
We provide you with 20 years of cash flow statements for Huntsman stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Huntsman stock. Explore the full financial landscape of Huntsman stock with our expertly curated income statements.
The information provided in this report about Huntsman stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.